{"public_id":"cl_dae71a4c8ad00d3131df023b118d79b0","status":"active","superseded_by_public_id":null,"corpus_id":25936189,"text":"Vinorelbine with G-CSF is a reliable and effective regimen for mobilization of autologous stem cells in bortezomib-pretreated myeloma patients.","confidence":0.96,"paper":{"corpus_id":25936189,"title":"Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.","url":"https://sah.borca.ai/papers/25936189"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_07ed74b7786c07a816db888e8a5ae0ca","name":"mobilization of autologous stem cells","description":"The process of collecting a patient's own stem cells for transplantation.","types":["procedure"],"url":"https://sah.borca.ai/concepts/co_07ed74b7786c07a816db888e8a5ae0ca"},{"public_id":"co_169aa132615f8f91c96509aa2fb1b0fb","name":"vinorelbine with G-CSF","description":"A stem cell mobilization regimen combining vinorelbine chemotherapy with granulocyte colony-stimulating factor.","types":["treatment regimen"],"url":"https://sah.borca.ai/concepts/co_169aa132615f8f91c96509aa2fb1b0fb"},{"public_id":"co_9ccf91e6bfaaa086856c8e50a9d3aa9c","name":"bortezomib-pretreated myeloma patients","description":"Multiple myeloma patients who had previously received bortezomib during induction treatment.","types":["patient group"],"url":"https://sah.borca.ai/concepts/co_9ccf91e6bfaaa086856c8e50a9d3aa9c"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_dae71a4c8ad00d3131df023b118d79b0"}